TRALI after the transfusion of cross-match-positive granulocytes

Transfusion. 2003 Dec;43(12):1683-6. doi: 10.1111/j.0041-1132.2003.00568.x.

Abstract

Background: TRALI is a serious complication of transfusion. WBC antibodies have been associated with TRALI. The importance of such antibodies for the transfusion of granulocytes is unknown.

Case report: A patient with hematologic malignancy and neutropenia-associated pneumonitis received 2 units of granulocytes despite a positive serologic cross- match. She developed severe TRALI after the second transfusion.

Results: The recipient's serum was reactive with immobilized HLA class I antigens from donor cells in a glycoprotein-specific assay. With an absorption-elution technique, at least anti-HLA-A2 could be identified as one of the donor-reactive antibodies in the recipient's serum.

Conclusion: Granulocyte-reactive antibodies are associated with TRALI in an alloimmunized patient receiving granulocyte transfusions. Performing a cross-match procedure may be helpful in preventing severe pulmonary reactions. Additional data are required to determine whether cross-matching as a regular practice in granulocyte transfusions would be beneficial for patients.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antineoplastic Agents / adverse effects
  • Blood Component Transfusion / adverse effects*
  • Blood Grouping and Crossmatching*
  • Fatal Outcome
  • Female
  • Humans
  • Leukemia / complications
  • Leukemia / drug therapy
  • Neutropenia / chemically induced
  • Neutropenia / immunology
  • Neutropenia / therapy*
  • Neutrophils / immunology*
  • Pneumonia / etiology*
  • Pneumonia / immunology*

Substances

  • Antineoplastic Agents